Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Vincerx Pharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 43 | 34 | −9 |
| Shares | 14.5M | 12.8M | −1.76M (−12.1%) |
| Value | $20.0M | $13.0M | −$7.03M (−35.1%) |
New holders (2)
Institutions that held Vincerx Pharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tejara Capital Ltd | 310,882 | $317.1K | 0.18% |
| Bank of Montreal | 12,399 | $13.0K | 0.00% |
Sold out (11)
Institutions that held Vincerx Pharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Holocene Advisors, LP | 758,214 | $1.05M |
| Russell Investments Group, Ltd. | 206,224 | $284.0K |
| Ergoteles LLC | 71,016 | $98.0K |
| Two Sigma Advisers, LP | 27,200 | $38.0K |
| Two Sigma Securities, LLC | 26,786 | $37.0K |
| Ground Swell Capital, LLC | 15,000 | $21.0K |
| Qube Research & Technologies Ltd | 14,878 | $21.0K |
| Hollencrest Capital Management | 10,000 | $14.0K |
| Cubist Systematic Strategies, LLC | 6,920 | $10.0K |
| UBS Group AG | 1,567 | $2.00K |
| BNP Paribas Arbitrage, SA | 597 | $824 |